Progress Toward Cutting Racial Mortality Disparities Stalling, Reversing
By Lori Solomon HealthDay Reporter
THURSDAY, Oct. 3, 2024 -- U.S. racial disparities in mortality decreased from 1999 to 2015 for Black men and to 2011 for Black women, followed by stagnation or regression, according to a study published online Sept. 30 in JAMA Network Open.
Adith S. Arun, from the Yale School of Medicine in New Haven, Connecticut, and colleagues sought to compare excess age-adjusted mortality rates (AAMRs) for the 15 primary underlying causes of death from 1999 to 2020 for Black and White U.S. populations.
The researchers found that the excess AAMR for Black individuals decreased steadily by an annual mean of 5.7 percent (1999 to 2015) for women and 5.2 percent (1999 to 2011) for men. Among men, primary factors associated with this decrease were cancer (5.3 percent mean annual excess AAMR change), heart disease (3.5 percent), accidents (60.5 percent), and HIV (7.0 percent). For women, heart disease (4.5 percent), diabetes (3.3 percent), cancer (3.7 percent), accidents (38.1 percent), and cerebrovascular diseases (2.7 percent) drove the decrease. From 2012 to 2019 for men and 2016 to 2019 for women, there were large increases in the mean annual excess AAMR from the period of decrease to no decrease for accidents, heart disease, cerebrovascular disease, and assault. From 2019 to 2020, COVID-19 accounted for 46.1 and 43.2 percent of this increase in all-cause excess AAMR among women and men, respectively.
"There is an urgent need to determine how best to regain the progress and implement evidence-based interventions to promote health equity," the authors write.
Several authors disclosed ties to the biotechnology and pharmaceutical industries.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
GLP-1 Receptor Agonist Use Linked to Lower Mortality in Seniors With Cancer, T2D
THURSDAY, July 24, 2025 -- For older patients with cancer and type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with lower all-cause...
Cancer Anxiety Impacts Family Members of Those Diagnosed With Cancer
WEDNESDAY, July 23, 2025 -- A cancer diagnosis places an emotional burden on the loved ones of those diagnosed, according to the results of a survey released by the Ohio State...
Race Definitions Have Limited Impact on Cancer Rates in Whites, Blacks, Asians
MONDAY, July 21, 2025 -- Race definitions have limited impact on cancer rates for Whites, Blacks, and Asians, but do impact rates in multiracial individuals, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.